US/UK/Canada

Share

About Us

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit professional organization with more than 2,700 members from over 45 countries dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy. For more information, visit www.ishlt.org.

Pick a time period -
Tags ( Active)

Current Models Overestimate Survival for Pulmonary Arterial Hypertension (PAH) Patients Awaiting Lung Transplant

Researchers create new equation to gauge patient survival to be presented at International Society for Heart and Lung Transplantation Annual MeetingMONTREAL, April 27, 2013 – The latest research in pulmonary arterial hypertension (PAH) will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study specifically reviewed past and current methods of predicting survival for PAH patients awaiting lung transplant. Results show that current models are overestimating

Hearts from Donation after Circulatory Death (DCD) Could Potentially Increase Transplants by 15 Percent

Study shows DCD hearts are a viable option for transplantationMONTREAL, April 25, 2013 – The results of a pre-clinical study show the viability of using hearts from donation after circulatory (or cardiac) Death (DCD) will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study focused on investigating the impact of varying periods of warm ischemia (is-KEE-mee-uh) (WI), cardiac function and evaluating pharmacological strategies to limit ischemic injury to the heart.

Sickest Children Not Benefiting from Recent Advances in Heart Transplant Therapy

Research indicates an overall decrease in pediatric waitlist mortality by 44 percentMONTREAL, April 25, 2013 – The latest research on children awaiting heart transplant will be presented today at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study set out to determine if waitlist survival has improved for children (under the age of 18) in the era of greater pediatric ventricular assist device (VAD) utilization using data from the Organ Procurement and Transplant Network (OPTN) (

Lung Transplants from Donation after Cardiac Death Sees Success in Multicenter Study

Results indicate survival rates comparable to traditional donation after brain deathMONTREAL, April 25, 2013 – A multicenter study focused on the outcomes of donation after cardiac death (DCD) in lung transplantation versus donation after brain death (DBD) will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The findings show favorable outcomes for lung transplant patients from DCD comparable to DBD. The results indicate positive survival rates at one month and one

Certain Bacteria May Build Organ Tolerance in Lung Transplant Patients

New research evaluates how microbes interact with and respond to transplanted lungsMONTREAL, April 25, 2013 – New research will be revealed today at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada to determine if there is a link between microbiota (microscopic living organisms of a region) and the development of transplant complications, especially chronic rejection.  Results indicate the nasopharynx (rear of the nasal cavity) serves as a reservoir for bacteria that can infect the newly

Post Approval Study Confirms Clinical Trial Results for HeartMate II® in Destination Therapy

Results presented today at the International Society for Heart and Lung TransplantationMONTREAL, April 25, 2013 – Today, researchers will reveal the latest findings on a post-approval study for destination therapy (DT) at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study focused on comparing commercial results to the multicenter clinical trial conducted from 2005-2010 using the HeartMate II® Left Ventricular Assist Device (LVAD). Results in a commercial patient care setting

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media